Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac <i>in-vitro</i> and <i>in-vivo</i> models.

Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models.

Sartiani, Laura; Bartolucci, Gianluca; Pallecchi, Marco; Spinelli, Valentina; Cerbai, Elisabetta.

Afiliação

Sartiani L; Section of Pharmacology, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Bartolucci G; Section of Medicinal Chemistry, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Pallecchi M; Section of Medicinal Chemistry, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Spinelli V; Section of Pharmacology, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Cerbai E; Section of Pharmacology, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.

Front Cardiovasc Med ; 9: 751499, 2022.

Article em En | MEDLINE | ID: mdl-36204580